Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius Kabi Norge is the Norwegian subsidiary of the global healthcare company Fresenius Kabi, specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company operates a major manufacturing facility in Halden, which is one of the group's most advanced plants for the production of sterile liquids using Blow-Fill-Seal technology. Their product portfolio includes a wide range of generic intravenous drugs, biosimilars for autoimmune and oncological conditions, and specialized clinical nutrition products. Fresenius Kabi Norge serves as a critical supplier to the Norwegian healthcare system, providing both pharmaceutical products and the medical devices required for their administration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresenius Kabi Norge.